The acquisition premium in M&A transactions in capital markets: the Pfizer-Hospira case
Cesa, Davide (A.A. 2014/2015) The acquisition premium in M&A transactions in capital markets: the Pfizer-Hospira case. Tesi di Laurea in Capital markets, LUISS Guido Carli, relatore Riccardo Bruno, pp. 121. [Master's Degree Thesis]
Full text for this thesis not available from the repository.
Abstract/Index
Theoretical background. Valuation. Acquisition premium. The Pfizer-Hospira merger.
References
Bibliografia: pp. 112-121.
| Thesis Type: | Master's Degree Thesis |
|---|---|
| Institution: | LUISS Guido Carli |
| Degree Program: | Master's Degree Programs > Master's Degree Program in Economics and Business Management (LM-77) |
| Chair: | Capital markets |
| Thesis Supervisor: | Bruno, Riccardo |
| Thesis Co-Supervisor: | De Vecchi, Luigi |
| Academic Year: | 2014/2015 |
| Session: | Autumn |
| Deposited by: | Alessandro Perfetti |
| Date Deposited: | 06 May 2016 13:23 |
| Last Modified: | 06 May 2016 13:23 |
| URI: | https://tesi.luiss.it/id/eprint/16155 |
Downloads
Downloads per month over past year
Repository Staff Only
 |
View Item |
